TRINITY BIOTECH INVT LTD's ticker is and the CUSIP is 89643QAB4. A total of 5 filers reported holding TRINITY BIOTECH INVT LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 2.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $37,754,000 | 0.0% | 53,175,000 | 0.0% | 0.82% | -17.4% |
Q3 2021 | $37,754,000 | 0.0% | 53,175,000 | 0.0% | 1.00% | -4.7% |
Q2 2021 | $37,754,000 | 0.0% | 53,175,000 | 0.0% | 1.05% | -30.4% |
Q1 2021 | $37,754,000 | 0.0% | 53,175,000 | 0.0% | 1.50% | +4.1% |
Q4 2020 | $37,754,000 | +3.4% | 53,175,000 | +0.5% | 1.45% | -26.5% |
Q3 2020 | $36,518,000 | +43.4% | 52,925,000 | +45.3% | 1.97% | -9.1% |
Q2 2020 | $25,457,000 | +19.5% | 36,425,000 | +19.7% | 2.17% | -5.0% |
Q1 2020 | $21,298,000 | -7.3% | 30,425,000 | 0.0% | 2.28% | -10.2% |
Q4 2019 | $22,971,000 | +26.4% | 30,425,000 | +15.1% | 2.54% | -4.2% |
Q3 2019 | $18,168,000 | -11.3% | 26,425,000 | 0.0% | 2.65% | +95.7% |
Q2 2019 | $20,480,000 | -0.7% | 26,425,000 | 0.0% | 1.36% | +113.7% |
Q1 2019 | $20,619,000 | -1.2% | 26,425,000 | 0.0% | 0.63% | +2.9% |
Q4 2018 | $20,876,000 | -1.3% | 26,425,000 | 0.0% | 0.62% | +22.7% |
Q3 2018 | $21,142,000 | +69.2% | 26,425,000 | +71.3% | 0.50% | +100.0% |
Q2 2018 | $12,494,000 | -25.9% | 15,425,000 | -24.5% | 0.25% | -7.7% |
Q1 2018 | $16,851,000 | -0.4% | 20,425,000 | 0.0% | 0.27% | -9.9% |
Q4 2017 | $16,912,000 | -10.3% | 20,425,000 | -12.8% | 0.30% | +7.1% |
Q3 2017 | $18,863,000 | -0.9% | 23,425,000 | 0.0% | 0.28% | -0.7% |
Q2 2017 | $19,033,000 | -0.3% | 23,425,000 | 0.0% | 0.28% | +2.5% |
Q1 2017 | $19,091,000 | -5.6% | 23,425,000 | -1.9% | 0.28% | -23.1% |
Q4 2016 | $20,234,000 | -16.4% | 23,875,000 | -5.9% | 0.36% | -6.0% |
Q3 2016 | $24,217,000 | +3.2% | 25,375,000 | 0.0% | 0.38% | +0.3% |
Q2 2016 | $23,472,000 | – | 25,375,000 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |